Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dual Antiplatelet Therapy With Ticagrelor and Acetylsalicylic Acid (ASA) vs. ASA Only After Isolated Coronary Artery Bypass Grafting in Patient With Acute Coronary Syndrome

NCT03560310 is registered in ClinicalTrials.gov with Vastra Gotaland Region as lead sponsor.

NCT NCT03560310
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03560310 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dual Antiplatelet Therapy With Ticagrelor and Acetylsalicylic Acid (ASA) vs. ASA Only After Isolated Coronary Artery Bypass Grafting in Patient With Acute Coronary Syndrome
Lead sponsor
Vastra Gotaland Region
Phase
Phase 4
Overall status
Active, not recruiting
Start date
June 29, 2018
Completion date
February 15, 2035
Enrollment
2,201 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndrome